Innate recognition of lipopolysaccharide by CD14 and toll-like receptor 4-MD-2: Unique roles for MD-2

International Immunopharmacology

Volumn 3, Issue 1, 2003, Pages 119-128

  Miyake, Kensuke ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Innate Immunity; MD 1; MD 2; Radioprotective 105 (RP105); Toll like receptor (TLR)

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; DIMER; ENDOTOXIN; LIGAND; LIPID A; PROTEIN; PROTEIN MD 1; PROTEIN MD 2; RADIOPROTECTIVE 105; RADIOPROTECTIVE AGENT; SIGNAL PEPTIDE; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANTIGEN RECOGNITION; ARTICLE; CELLULAR DISTRIBUTION; DROSOPHILA; DRUG TARGETING; FUNGUS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; LIGAND BINDING; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD14; ANTIGENS, SURFACE; HUMANS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ANTIGEN 96; MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 0037238671     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(02)00258-8     Document Type: Article

References (73)

1. Janeway C.A. Jr., Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 20:2002;197-216.
2. Aderem A., Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature. 406:2000;782-787.
3. Fearon D.T., Locksley R.M. The instructive role of innate immunity in the acquired immune response. Science. 272:1996;50-53.
4. Ulevitch R.J., Tobias P.S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13:1995;437-457.
5. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 249:1990;1431-1433.
6. Medzhitov R., Preston-Hurlburt P., Janeway C.A. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 388:1997;394-397.
7. Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K.et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189:1999;1777-1782.
8. Schumann R.R., Leong S.R., Flaggs G.W., Gray P.W., Wright S.D.et al. Structure and function of lipopolysaccharide binding protein. Science. 249:1990;1429-1431.
9. Haziot A., Ferrero E., Kontgen F., Hijiya N., Yamamoto S.et al. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity. 4:1996;407-414.
10. Pugin J., Heumann I.D., Tomasz A., Kravchenko V.V., Akamatsu Y.et al. CD14 is a pattern recognition receptor. Immunity. 1:1994;509-516.
11. Wang P.Y., Kitchens R.L., Munford R.S. Phosphatidylinositides bind to plasma membrane CD14 and can prevent monocyte activation by bacterial lipopolysaccharide. J. Biol. Chem. 273:1998;24309-24313.
12. Devitt A., Moffatt O.D., Raykundalia C., Capra J.D., Simmons D.L.et al. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature. 392:1998;505-509.
13. Delude R.L., Savedra R. Jr., Zhao H., Thieringer R., Yamamoto S.et al. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc. Natl. Acad. Sci. U. S. A. 92:1995;9288-9292.
14. Lynn W.A., Golenbock D.T. Lipopolysaccharide antagonists. Immunol. Today. 13:1992;271-276.
15. Rock F.L., Hardiman G., Timans J.C., Kastelein R.A., Bazan J.F. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. U. S. A. 95:1998;588-593.
16. Poltorak A., He X., Smirnova I., Liu M.Y., Huffel C.V.et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 282:1998;2085-2088.
17. Qureshi S.T., Lariviere L., Leveque G., Clermont S., Moore K.J.et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 189:1999;615-625.
18. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T.et al. Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:1999;3749-3752.
19. O'Neill L.A., Dinarello C.A. The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense. Immunol. Today. 21:2000;206-209.
20. Wesche H., Henzel W.J., Shillinglaw W., Li S., Cao Z. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity. 7:1997;837-847.
21. Cao Z., Henzel W.J., Gao X. IRAK: a kinase associated with the interleukin-1 receptor. Science. 271:1996;1128-1131.
22. Cao Z., Xiong J., Takeuchi M., Kurama T., Goeddel D.V. TRAF6 is a signal transducer for interleukin-1. Nature. 383:1996;443-446.
23. Muzio M., Natoli G., Saccani S., Levrero M., Mantovani A. The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J. Exp. Med. 187:1998;2097-2101.
24. Kawai T., Adachi O., Ogawa T., Takeda K., Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 11:1999;115-122.
25. Suzuki N., Suzuki S., Duncan G.S., Millar D.G., Wada T.et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature. 416:2002;750-756.
26. Lomaga M.A., Yeh W.C., Sarosi I., Duncan G.S., Furlonger C.et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13:1999;1015-1024.
27. Kirschning C.J., Wesche H., Merrill Ayres T., Rothe M. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J. Exp. Med. 188:1998;2091-2097.
28. Miyake K., Yamashita Y., Ogata M., Sudo T., Kimoto M. RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. J. Immunol. 154:1995;3333-3340.
29. Miyake K., Shimazu R., Kondo J., Niki T., Akashi S.et al. Mouse MD-1, a molecule that is physically associated with RP105 and positively regulates its expression. J. Immunol. 161:1998;1348-1353.
30. Miyake K., Yamashita Y., Hitoshi Y., Takatsu K., Kimoto M. Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells. J. Exp. Med. 180:1994;1217-1224.
31. Burk O., Klempnauer K.H. Estrogen-dependent alterations in differentiation state of myeloid cells caused by a v-myb/estrogen receptor fusion protein. EMBO J. 10:1991;3713-3719.
32. da Silva Correia J., Soldau K., Christen U., Tobias P.S., Ulevitch R.J. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. Transfer from CD14 to TLR4 and MD-2. J. Biol. Chem. 276:2001;21129-21135.
33. Ohnishi T., Muroi M., Tanamoto K. N-linked glycosylations at Asn(26) and Asn(114) of human MD-2 are required for toll-like receptor 4-mediated activation of NF-kappaB by lipopolysaccharide. J. Immunol. 167:2001;3354-3359.
34. Schromm A.B., Lien E., Henneke P., Chow J.C., Yoshimura A.et al. Molecular genetic analysis of an endotoxin nonresponder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling. J. Exp. Med. 194:2001;79-88.
35. Visintin A., Mazzoni A., Spitzer J.A., Segal D.M. Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. Proc. Natl. Acad. Sci. U. S. A. 98:2001;12156-12161.
36. Nagai Y., Akashi S., Nagafuku M., Ogata M., Iwakura Y.et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3:2002;667-672.
37. Nagai Y., Shimazu R., Ogata H., Akashi S., Sudo K.et al. Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Blood. 99:2002;1699-1705.
38. Miura Y., Shimazu R., Miyake K., Akashi S., Ogata H.et al. RP105 is associated with MD-1 and transmits an activation signal in human B cells. Blood. 92:1998;2815-2822.
39. Randow F., Seed B. Endoplasmic reticulum chaperone gp96 is required for innate immunity but not cell viability. Nat. Cell Biol. 3:2001;891-896.
40. da Silva Correia J., Ulevitch R.J. MD-2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor. J. Biol. Chem. 277:2002;1845-1854.
41. Viriyakosol S., Tobias P.S., Kitchens R.L., Kirkland T.N. MD-2 binds to bacterial lipopolysaccharide. J. Biol. Chem. 276:2001;38044-38051.
42. Mancek M., Pristovsek P., Jerala R. Identification of LPS-binding peptide fragment of MD-2, a toll-receptor accessory protein. Biochem. Biophys. Res. Commun. 292:2002;880-885.
43. Beamer L.J., Carroll S.F., Eisenberg D. Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. Science. 276:1997;1861-1864.
44. Ding A.H., Porteu F., Sanchez E., Nathan C.F. Shared actions of endotoxin and taxol on TNF receptors and TNF release. Science. 248:1990;370-372.
45. Kawasaki K., Akashi S., Shimazu R., Yoshida T., Miyake K.et al. Mouse toll-like receptor 4·MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by taxol. J. Biol. Chem. 275:2000;2251-2254.
46. Kawasaki K., Gomi K., Nishijima M. Cutting edge: Gln22 of mouse MD-2 is essential for species-specific lipopolysaccharide mimetic action of taxol. J. Immunol. 166:2001;11-14.
47. Kovach N.L., Yee E., Munford R.S., Raetz C.R., Harlan J.M. Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo. J. Exp. Med. 172:1990;77-84.
48. Akashi S., Nagai Y., Ogata H., Oikawa M., Fukase K.et al. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int. Immunol. 13:2001;1595-1599.
49. Poltorak A., Ricciardi-Castagnoli P., Citterio S., Beutler B. Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation. Proc. Natl. Acad. Sci. U. S. A. 97:2000;2163-2167.
50. Lien E., Means T.K., Heine H., Yoshimura A., Kusumoto S.et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 105:2000;497-504.
51. Hajjar A.M., Ernst R.K., Tsai J.H., Wilson C.B., Miller S.I. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat. Immunol. 3:2002;354-359.
52. Muroi M., Ohnishi T., Tanamoto K. MD-2, a novel accessory molecule, is involved in species-specific actions of salmonella lipid A. Infect. Immun. 70:2002;3546-3550.
53. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P.et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1:2000;398-401.
54. Haynes L.M., Moore D.D., Kurt-Jones E.A., Finberg R.W., Anderson L.J.et al. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J. Virol. 75:2001;10730-10737.
55. Rowinsky E.K., Donehower R.C. Paclitaxel (taxol). N. Engl. J. Med. 332:1995;1004-1014.
56. Kawasaki K., Akashi S., Shimazu R., Yoshida T., Miyake K.et al. Involvement of TLR4/MD-2 complex in species-specific lipopolysaccharide-mimetic signal transduction by Taxol. J. Endotoxin Res. 7:2001;232-236.
57. Vabulas R.M., Ahmad-Nejad P., Ghose S., Kirschning C.J., Issels R.D.et al. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J. Biol. Chem. 277:2002;15107-15112.
58. Asea A., Rehli M., Kabingu E., Boch J.A., Bare O.et al. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 277:2002;15028-15034.
59. Bulut Y., Faure E., Thomas L., Karahashi H., Michelsen K.S.et al. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J. Immunol. 168:2002;1435-1440.
60. Sasu S., LaVerda D., Qureshi N., Golenbock D.T., Beasley D. Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation. Circ. Res. 89:2001;244-250.
61. Vabulas R.M., Ahmad-Nejad P., da Costa C., Miethke T., Kirschning C.J.et al. Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J. Biol. Chem. 276:2001;31332-31339.
62. Ohashi K., Burkart V., Flohe S., Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J. Immunol. 164:2000;558-561.
63. Okamura Y., Watari M., Jerud E.S., Young D.W., Ishizaka S.T.et al. The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem. 276:2001;10229-10233.
64. Guillot L., Balloy V., McCormack F.X., Golenbock D.T., Chignard M.et al. Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J. Immunol. 168:2002;5989-5992.
65. Re F., Strominger J.L. Monomeric recombinant MD-2 binds TLR4 tightly and confers LPS responsiveness. J. Biol. Chem. 277:2002;23427-23432.
66. Zarember K.A., Godowski P.J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168:2002;554-561.
67. Chan V.W., Mecklenbrauker I., Su I., Texido G., Leitges M.et al. The molecular mechanism of B cell activation by toll-like receptor protein RP-105. J. Exp. Med. 188:1998;93-101.
68. Grumont R.J., Rourke I.J., O'Reilly L.A., Strasser A., Miyake K.et al. B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J. Exp. Med. 187:1998;663-674.
69. Ogata H., Su I.-H., Miyake K., Nagai Y., Akashi S.et al. The Toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J. Exp. Med. 192:2000;23-30.
70. Fugier-Vivier I., de Bouteiller O., Guret C., Fossiez F., Banchereau J.et al. Molecular cloning of human RP105. Eur. J. Immunol. 27:1997;1824-1827.
71. Means T.K., Jones B.W., Schromm A.B., Shurtleff B.A., Smith J.A.et al. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses. J. Immunol. 166:2001;4074-4082.
72. Lee J.Y., Sohn K.H., Rhee S.H., Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 276:2001;16683-16689.
73. Guillot L., Balloy V., McCormack F.X., Golenbock D.T., Chignard M.et al. Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J. Immunol. 168:2002;5989-5992.